Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

renal · Mechanism Report

Are SHROOM3 genetic variants linked to reduced kidney function and altered magnesium handling?

Variants near SHROOM3 are robustly associated with decreased kidney function and with differences in systemic magnesium handling.

PlausibleJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Genetic variants near SHROOM3 are associated with differences in kidney function and have been linked to altered magnesium handling in population studies.

laying out figure…
2 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim reports that common genetic variants at the SHROOM3 locus, notably rs17319721, correlate with lower eGFR, higher BUN, altered albuminuria, and changes in serum magnesium in population studies. Mechanistically, the risk allele increases SHROOM3 expression, promoting fibrotic remodeling of renal tubules and thereby impairing filtration and indirectly altering tubular magnesium reabsorption.

Verified conclusion

An assessment of the genetic relationship between the SHROOM3 locus, kidney function, and systemic magnesium handling shows that genetic variants in this region are robustly linked to renal health.

Clinical and effectiveness evidence

  • Association with Renal Decline: Large-scale genome-wide association studies (GWAS) consistently link genetic variants near SHROOM3 with decreased kidney function. The most prominent variant is the intronic single nucleotide polymorphism (SNP) rs17319721. The minor A allele of this SNP is strongly associated with a lower estimated glomerular filtration rate (eGFR) and an increased risk of chronic kidney disease (CKD).
  • Renal Biomarkers: Beyond eGFR, SHROOM3 variants are significantly associated with elevated blood urea nitrogen (BUN) and altered urinary albumin-to-creatinine ratios (uACR) across diverse European and East Asian cohorts.
  • Altered Magnesium Handling: Population-based genetic studies, including major meta-analyses from the CHARGE Consortium, have identified SHROOM3 as a key locus associated with variations in serum magnesium levels. These variants are also linked to baseline serum magnesium variations and hypomagnesemia risk in specific populations, such as individuals with type 2 diabetes.

Mechanistic explanations

  • Expression Modulation: The rs17319721 variant acts as a cis-acting expression quantitative trait locus (eQTL). The risk-associated allele is linked to increased SHROOM3 expression in human renal tissues.
  • Fibrotic Remodeling: Elevated SHROOM3 expression enhances transforming growth factor-beta 1 (TGF-beta1) signaling. This drives actin cytoskeleton remodeling and epithelial-to-mesenchymal transition, culminating in progressive renal interstitial fibrosis and a subsequent decline in glomerular filtration capacity.
  • Indirect Magnesium Regulation: Unlike primary magnesium transporters (e.g., TRPM6, CNNM2), SHROOM3 does not directly transport magnesium. Instead, it regulates epithelial cell shape, cell-cell adhesion, and renal tubular architecture. Alterations in SHROOM3 expression are believed to affect magnesium handling indirectly by modifying the structural integrity of the renal tubules where magnesium reabsorption occurs.

Bottom line

Genetic variations near SHROOM3 are robustly associated with reduced kidney function and altered serum magnesium handling. This occurs through a mechanism where the risk allele increases SHROOM3 expression, promoting renal interstitial fibrosis and altering tubular epithelial architecture, which subsequently compromises filtration and electrolyte homeostasis.

References

  1. Validated SNPs for eGFR and their associations with albuminuria. — pmc.ncbi.nlm.nih.gov ↗
  2. The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review — pmc.ncbi.nlm.nih.gov ↗
  3. Associations of a SHROOM3 variant with mild renal impairment and depressive symptoms in a Chinese Han population — researchsquare.com ↗
  4. Genome-wide association study of serum magnesium in type 2 diabetes — genesandnutrition.biomedcentral.com ↗
  5. Genome-Wide Association Studies of Serum Magnesium, Potassium, and Sodium Concentrations Identify Six Loci Influencing Serum Magnesium Levels — dx.plos.org ↗
  6. The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review — journals.sagepub.com ↗
  7. Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes urinary albumin-to-creatinine ratio detect albumin leakage from kidney barrier injury?→Plausible8 sourcesCan impaired kidney filtration raise blood TMAO levels independently of gut microbial production?→